ultrashort-acting benzodiazepine agonists (GSK)

N/A

Report date: 2025/03/20 09:15:09
NME

Base Information

Drug Nameultrashort-acting benzodiazepine agonists (GSK)
Drug Alias NameUSA BZD (GSK)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A